| Eosinophils in inflammatory bowel disease RT Filippone, L Sahakian, V Apostolopoulos, K Nurgali Inflammatory bowel diseases 25 (7), 1140-1151, 2019 | 73 | 2019 |
| Inhibition of APE1/Ref-1 redox signaling alleviates intestinal dysfunction and damage to myenteric neurons in a mouse model of spontaneous chronic colitis L Sahakian, RT Filippone, R Stavely, AM Robinson, XS Yan, R Abalo, ... Inflammatory bowel diseases 27 (3), 388-406, 2021 | 28 | 2021 |
| Divergent adaptations in autonomic nerve activity and neuroimmune signaling associated with the severity of inflammation in chronic colitis R Stavely, AA Rahman, L Sahakian, MD Prakash, AM Robinson, ... Inflammatory Bowel Diseases 28 (8), 1229-1243, 2022 | 10 | 2022 |
| Oxidative Stress-Induced HMGB1 Translocation in Myenteric Neurons Contributes to Neuropathy in Colitis R Stavely, L Sahakian, RT Filippone, V Stojanovska, JC Bornstein, ... Biomolecules 12 (12), 1831, 2022 | 7 | 2022 |
| Oxidative Stress and Neural Dysfunction in Gastrointestinal Diseases: Can Stem Cells Offer a Solution? R Stavely, LC Ott, L Sahakian, N Rashidi, S Sakkal, K Nurgali Stem Cells Translational Medicine 12 (12), 801-810, 2023 | 6 | 2023 |
| APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease L Sahakian, AM Robinson, L Sahakian, R Stavely, MR Kelley, K Nurgali Biomolecules 13 (11), 1569, 2023 | 4 | 2023 |
| The role of the gastrointestinal barrier in obesity‐associated systemic inflammation A Acciarino, S Diwakarla, J Handreck, C Bergola, L Sahakian, ... Obesity Reviews 25 (3), e13673, 2024 | 3 | 2024 |
| Gastrointestinal consequences of lipopolysaccharide-induced lung inflammation RM McQuade, M Bandara, S Diwakarla, L Sahakian, MN Han, ... Inflammation Research 72 (1), 57-74, 2023 | 3 | 2023 |
| Dimethyl fumarate modulates the Duchenne muscular dystrophy disease program following short-term treatment in mdx mice CA Timpani, S Kourakis, DA Debruin, DG Campelj, N Pompeani, ... bioRxiv, 2022.09. 15.508124, 2022 | 2 | 2022 |
| Molecular Targets to Alleviate Enteric Neuropathy and Gastrointestinal Dysfunction L Sahakian, R McQuade, R Stavely, A Robinson, RT Filippone, ... The Enteric Nervous System II, 221-228, 2023 | 1 | 2023 |
| Tu1728 REF-1 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: EFFICACY, MECHANISMS OF ACTION, AND CLINICAL APPLICATIONS K Nurgali, L Sahakian, AM Robinson, R Stavely, R Eri, V Apostolopoulos, ... Gastroenterology 166 (5), S-1396-S-1397, 2024 | | 2024 |
| Transcriptomic analysis of differentially expressed genes in the Winnie mouse model of chronic colitis R Ephraim, S Fraser, J Devereaux, L Sahakian, R Stavely, M Davidson, ... | | 2023 |
| Sa1755 APE1/REF-1 AS A NOVEL MOLECULAR TARGET FOR IBD TREATMENT K Nurgali, L Sahakian, AM Robinson, R Stavely, RT Filippone, R Eri, ... Gastroenterology 164 (6), S-418, 2023 | | 2023 |
| Apurinic/apyrimidinic endonuclease 1/redox factor-1 as a novel therapeutic target for inflammatory bowel disease L Sahakian, R Filippone, X Yan, R Abalo, R Eri, J Bornstein, M Kelley, ... NEUROGASTROENTEROLOGY AND MOTILITY 32, 2020 | | 2020 |
